Literature DB >> 25544361

Nutlin-3-induced redistribution of chromatin-bound IFI16 in human hepatocellular carcinoma cells in vitro is associated with p53 activation.

Xin-li Shi1, Jing Yang2, Nan Mao3, Jing-hua Wu4, Lai-feng Ren2, Yuan Yang2, Xiao-lin Yin5, Lin Wei5, Ming-yuan Li6, Bao-ning Wang2.   

Abstract

AIM: Interferon-γ inducible protein 16 (IFI16), a DNA sensor for DNA double-strand break (DSB), is expressed in most human hepatocellular carcinoma cell (HCC) lines. In this study we investigated the re-localization of chromatin-bound IFI16 by Nutlin-3, a DNA damage agent, in HCC cells in vitro, and the potential mechanisms.
METHODS: Human HCC SMMC-7721 (wild-type TP53), Huh-7 (mutant TP53), Hep3B (null TP53) and normal fetal liver L02 cell lines were examined. DSB damage in HCC cells was detected via γH2AX expression and foci formation assay. The expression of IFI16 and IFNB mRNA was measured using RT-PCR, and subcellular localization and expression of the IFI16 protein were detected using chromatin fractionation, Western blot analysis, and fluorescence microscopy.
RESULTS: Treatment of SMMC-7721 cells with Nutlin-3 (10 μmol/L) or etoposide (40 μmol/L) induced significant DSB damage. In SMMC-7721 cells, Nutlin-3 significantly increased the expression levels of IFI16 and IFNB mRNA, and partially redistributed chromatin-bound IFI16 protein to the cytoplasm. These effects were blocked by pretreatment with pifithrin-α, a p53 inhibitor. Furthermore, Nutlin-3 did not induce ectopic expression of IFI16 protein in Huh-7 and Hep3B cells. Moreover, the association of IFI16 with chromatin and Nutlin-3-induced changes in localization were not detected in L02 cells.
CONCLUSION: Nutlin-3 regulates the subcellular localization of IFI16 in HCC cells in vitro in a p53-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25544361      PMCID: PMC4326783          DOI: 10.1038/aps.2014.106

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  49 in total

1.  Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16.

Authors:  Tuo Li; Benjamin A Diner; Jin Chen; Ileana M Cristea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-12       Impact factor: 11.205

Review 2.  The HIN-200 family: more than interferon-inducible genes?

Authors:  Louise E A Ludlow; Ricky W Johnstone; Christopher J P Clarke
Journal:  Exp Cell Res       Date:  2005-08-01       Impact factor: 3.905

Review 3.  The PYHIN protein family as mediators of host defenses.

Authors:  Stefan A Schattgen; Katherine A Fitzgerald
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

4.  Ursolic acid induces human hepatoma cell line SMMC-7721 apoptosis via p53-dependent pathway.

Authors:  Yan-Xia Yu; Zhen-Lun Gu; Jiang-Lin Yin; Wen-Hsien Chou; Chi-Yi Kwok; Zheng-Hong Qin; Zhong-Qin Liang
Journal:  Chin Med J (Engl)       Date:  2010-07       Impact factor: 2.628

5.  MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.

Authors:  Jiabei Wang; Tongsen Zheng; Xi Chen; Xuan Song; Xianzhi Meng; Nishant Bhatta; Shangha Pan; Hongchi Jiang; Lianxin Liu
Journal:  J Gastroenterol Hepatol       Date:  2011-02       Impact factor: 4.029

6.  IFI16 in human prostate cancer.

Authors:  Fatouma Alimirah; Jianming Chen; Francesca J Davis; Divaker Choubey
Journal:  Mol Cancer Res       Date:  2007-03-05       Impact factor: 5.852

7.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

Authors:  P G Komarov; E A Komarova; R V Kondratov; K Christov-Tselkov; J S Coon; M V Chernov; A V Gudkov
Journal:  Science       Date:  1999-09-10       Impact factor: 47.728

8.  Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation.

Authors:  Yuudai Kondo; Kentaro Nagai; Shingo Nakahata; Yusuke Saito; Tomonaga Ichikawa; Akira Suekane; Tomohiko Taki; Reika Iwakawa; Masato Enari; Masafumi Taniwaki; Jun Yokota; Sumio Sakoda; Kazuhiro Morishita
Journal:  Cancer Sci       Date:  2012-02-23       Impact factor: 6.716

Review 9.  HIN-200: a novel family of IFN-inducible nuclear proteins expressed in leukocytes.

Authors:  M J Dawson; J A Trapani
Journal:  J Leukoc Biol       Date:  1996-09       Impact factor: 4.962

10.  Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells.

Authors:  Mairaj Ahmed Ansari; Vivek Vikram Singh; Sujoy Dutta; Mohanan Valiya Veettil; Dipanjan Dutta; Leela Chikoti; Jie Lu; David Everly; Bala Chandran
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

View more
  5 in total

1.  Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells.

Authors:  Bing Liu; Jingyuan Song; Haote Han; Zhengping Hu; Na Chen; Jing Cui; Joanne Aiko Matsubara; Jingxiang Zhong; Hetian Lei
Journal:  Lab Invest       Date:  2019-08-22       Impact factor: 5.662

Review 2.  DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic Alterations.

Authors:  Mankgopo Magdeline Kgatle; Catherine Wendy Spearman; Asgar Ali Kalla; Henry Norman Hairwadzi
Journal:  Oxid Med Cell Longev       Date:  2017-06-27       Impact factor: 6.543

3.  Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients.

Authors:  Shahrzad Hamldar; Seyed Jalal Kiani; Majid Khoshmirsafa; Javid Sadri Nahand; Hamed Mirzaei; AliReza Khatami; Roya Kahyesh-Esfandiary; Khadijeh Khanaliha; Ahmad Tavakoli; Kimiya Babakhaniyan; Farah Bokharaei-Salim
Journal:  Biologicals       Date:  2022-09-13       Impact factor: 1.760

4.  Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.

Authors:  Zhi Wang; Wenbin Gou; Ming Liu; Wei Sang; Hui Chu; Wei Zhang
Journal:  Med Sci Monit       Date:  2015-10-23

Review 5.  MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?

Authors:  Samy A Azer
Journal:  J Clin Med       Date:  2018-03-27       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.